Kaila Krum analyst

Currently out of the existing stock ratings of Kaila Krum, 72 are a BUY (93.51%), 5 are a HOLD (6.49%).

Kaila Krum

Work Performance Price Targets & Ratings Chart

Analyst Kaila Krum, carries an average stock price target met ratio of 67.71% that have a potential upside of 24.33% achieved within 215 days. Previously, Kaila Krum worked at TRUIST.

Kaila Krum’s has documented 154 price targets and ratings displayed on 19 stocks. The coverage was on Healthcare, Industrials, Financial Services sectors.

Most recent stock forecast was given on KIDS, Orthopediatrics Corp at 15-Apr-2024.

Wall Street Analyst Kaila Krum

Analyst best performing recommendations are on VCEL (VERICEL CORP ORD).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 5/8/2020. The price target of $130 was fulfilled within 3 days with a profit of $5.48 (4.4%) receiving and performance score of 14.67.

Average potential price target upside

BSX Boston Scientific Corp IART Integra LifeSciences Holdings IRT Independence Realty Trust IRTC iRhythm Technologies KIDS Orthopediatrics Corp SPNE SeaSpine Holdings Corp SYK Stryker VCEL Vericel Corp Ord ZBH Zimmer Biomet Holdings MDT Medtronic PLC NVRO Nevro Corp AZYO Aziyo Biologics AXNX Axonics Modulation Technologies NUVA NuVasive AIR AAR Corp AX Axos Financial BEAT Heartbeam GMED Globus Medical SIBN Si-Bone

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 07-Oct-2026

$48

$5.27 (12.33%)

$89

Hold Since 05-Oct-2026

$48

$5.27 (12.33%)

$50

7 days ago
(05-Oct-2026)

24/34 (70.59%)

$5.6 (13.21%)

249

Hold Since 30-Jul-2026

$48

$5.27 (12.33%)

$50

18 days ago
(24-Sep-2026)

18/25 (72%)

$3.32 (7.43%)

197

Buy Since 16-Jan-2026

$65

$22.27 (52.12%)

$85

21 days ago
(21-Sep-2026)

0/4 (0%)

$21.28 (48.67%)

Buy Since 06-Feb-2020

$56

$13.27 (31.06%)

$60

1 months 3 days ago
(09-Sep-2026)

22/37 (59.46%)

$11.04 (24.56%)

253

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?